ArticleFrontiers in cardiovascular medicine2025
Associations between life's essential 8 and the risk of cardiovascular disease in national US population: evidence from NHANES 2005-2018.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association between cardiovascular health measured by Life's Essential 8 and depressive symptoms.Epidemiology and health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardiovascular health (CVH) is closely linked to cardiovascular disease (CVD)-specific mortality, yet research on Life's Essential 8 (LE8), a new CVH indicator, and its association with CVD risk is limited. Objective: This study aims to explore the association between LE8 and CVD risk in US adults. Methods: A total of 22,298 participants were included in this cross-sectional study from the National Health and Nutrition Examination Survey (NHANES) between 2005 and 2018. LE8 scores were categorized into low, moderate, and high groups. Multivariate logistic regression and restricted cubic spline (RCS) models were employed to examine the association between LE8 scores and CVD risk. Results: In the multivariate-adjusted model, individuals with moderate and high LE8 scores exhibited a 53% (odds ratio [OR] = 0.47, 95% confidence interval [CI]: 0.41-0.54) and 77% (OR = 0.23, 95% CI: 0.18-0.30) reduction in total CVD risk compared to those with low LE8 scores. RCS analyses revealed an inverse dose-response relationship between LE8 scores and total CVD risk. A consistently negative association was observed between LE8 scores and the risk of CVD subtypes, including congestive heart failure, coronary heart disease, angina pectoris, heart attack, and stroke. Subgroup analyses indicated a more pronounced inverse association between LE8 scores and total CVD risk among participants under 50 years old and with a family history of CVD. Conclusions: These findings suggest a strong inverse relationship between LE8 and CVD risk. Improving CVH through adherence to LE8 guidelines has significant potential to reduce the burden of CVD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.